RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.

Authors:
Lin W; Zhang J; Zhang J; Liu X; Fei Z and 9 more

Journal:
J Cell Mol Med

Publication Year: 2009

DOI:
10.1111/j.1582-4934.2008.00499.x

PMCID:
PMC4515075

PMID:
18798870

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cell Mol Med

Abbreviation: J Cell Mol Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C > T mutation in murine …
Yang L; Liu Z; Sun J and 3 more (2024) - Transparency Score: 4/6
A systematic review on deep learning-based automated cancer diagnosis models.
Tandon R; Agrawal S; Rathore NPS and 2 more (2024) - Transparency Score: 3/6
Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H and 2 more (2024) - Transparency Score: 4/6
Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunothera…
Fu Y; Sun S; Shi D and 1 more (2024) - Transparency Score: 4/6
C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-caten…
Wu Q; Chen Q; Xu D and 12 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors thank Prof. E.W. Khandjian (Département de biologie médicale, Faculté de médecine, Université Laval, Québec, Canada) for kindly providing anti MSP58 polyclonal serum. This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2006AA02Z194), the Program for Scholars and Innovative Research Team in University (No. PCSIRT0459) and the National Natural Science Foundation of China (No. 30700918, 30670452; Key Program, No. 30830054) and Natural Science Foundation of Shaanxi Province of China (No., 2008K09-09)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025